indicazioni alla terapia adiuvante...ialt advances m management of early stage non small cell lung...
TRANSCRIPT
![Page 1: Indicazioni alla terapia adiuvante...IALT Advances m Management of Early Stage Non Small Cell Lung Cancer -Accrual 1867 / 3300 - Median Survival 50.8 months vs 44.4 months .Patient](https://reader030.vdocuments.site/reader030/viewer/2022011915/5fcdef678e5f9f28974e1d56/html5/thumbnails/1.jpg)
Indicazioni alla terapiaadiuvante
Vito LorussoDipartimento di Oncologia Medica
Istituto Oncologico Bari
![Page 2: Indicazioni alla terapia adiuvante...IALT Advances m Management of Early Stage Non Small Cell Lung Cancer -Accrual 1867 / 3300 - Median Survival 50.8 months vs 44.4 months .Patient](https://reader030.vdocuments.site/reader030/viewer/2022011915/5fcdef678e5f9f28974e1d56/html5/thumbnails/2.jpg)
![Page 3: Indicazioni alla terapia adiuvante...IALT Advances m Management of Early Stage Non Small Cell Lung Cancer -Accrual 1867 / 3300 - Median Survival 50.8 months vs 44.4 months .Patient](https://reader030.vdocuments.site/reader030/viewer/2022011915/5fcdef678e5f9f28974e1d56/html5/thumbnails/3.jpg)
![Page 4: Indicazioni alla terapia adiuvante...IALT Advances m Management of Early Stage Non Small Cell Lung Cancer -Accrual 1867 / 3300 - Median Survival 50.8 months vs 44.4 months .Patient](https://reader030.vdocuments.site/reader030/viewer/2022011915/5fcdef678e5f9f28974e1d56/html5/thumbnails/4.jpg)
![Page 5: Indicazioni alla terapia adiuvante...IALT Advances m Management of Early Stage Non Small Cell Lung Cancer -Accrual 1867 / 3300 - Median Survival 50.8 months vs 44.4 months .Patient](https://reader030.vdocuments.site/reader030/viewer/2022011915/5fcdef678e5f9f28974e1d56/html5/thumbnails/5.jpg)
![Page 6: Indicazioni alla terapia adiuvante...IALT Advances m Management of Early Stage Non Small Cell Lung Cancer -Accrual 1867 / 3300 - Median Survival 50.8 months vs 44.4 months .Patient](https://reader030.vdocuments.site/reader030/viewer/2022011915/5fcdef678e5f9f28974e1d56/html5/thumbnails/6.jpg)
![Page 7: Indicazioni alla terapia adiuvante...IALT Advances m Management of Early Stage Non Small Cell Lung Cancer -Accrual 1867 / 3300 - Median Survival 50.8 months vs 44.4 months .Patient](https://reader030.vdocuments.site/reader030/viewer/2022011915/5fcdef678e5f9f28974e1d56/html5/thumbnails/7.jpg)
![Page 8: Indicazioni alla terapia adiuvante...IALT Advances m Management of Early Stage Non Small Cell Lung Cancer -Accrual 1867 / 3300 - Median Survival 50.8 months vs 44.4 months .Patient](https://reader030.vdocuments.site/reader030/viewer/2022011915/5fcdef678e5f9f28974e1d56/html5/thumbnails/8.jpg)
![Page 9: Indicazioni alla terapia adiuvante...IALT Advances m Management of Early Stage Non Small Cell Lung Cancer -Accrual 1867 / 3300 - Median Survival 50.8 months vs 44.4 months .Patient](https://reader030.vdocuments.site/reader030/viewer/2022011915/5fcdef678e5f9f28974e1d56/html5/thumbnails/9.jpg)
![Page 10: Indicazioni alla terapia adiuvante...IALT Advances m Management of Early Stage Non Small Cell Lung Cancer -Accrual 1867 / 3300 - Median Survival 50.8 months vs 44.4 months .Patient](https://reader030.vdocuments.site/reader030/viewer/2022011915/5fcdef678e5f9f28974e1d56/html5/thumbnails/10.jpg)
![Page 11: Indicazioni alla terapia adiuvante...IALT Advances m Management of Early Stage Non Small Cell Lung Cancer -Accrual 1867 / 3300 - Median Survival 50.8 months vs 44.4 months .Patient](https://reader030.vdocuments.site/reader030/viewer/2022011915/5fcdef678e5f9f28974e1d56/html5/thumbnails/11.jpg)
![Page 12: Indicazioni alla terapia adiuvante...IALT Advances m Management of Early Stage Non Small Cell Lung Cancer -Accrual 1867 / 3300 - Median Survival 50.8 months vs 44.4 months .Patient](https://reader030.vdocuments.site/reader030/viewer/2022011915/5fcdef678e5f9f28974e1d56/html5/thumbnails/12.jpg)
![Page 13: Indicazioni alla terapia adiuvante...IALT Advances m Management of Early Stage Non Small Cell Lung Cancer -Accrual 1867 / 3300 - Median Survival 50.8 months vs 44.4 months .Patient](https://reader030.vdocuments.site/reader030/viewer/2022011915/5fcdef678e5f9f28974e1d56/html5/thumbnails/13.jpg)
![Page 14: Indicazioni alla terapia adiuvante...IALT Advances m Management of Early Stage Non Small Cell Lung Cancer -Accrual 1867 / 3300 - Median Survival 50.8 months vs 44.4 months .Patient](https://reader030.vdocuments.site/reader030/viewer/2022011915/5fcdef678e5f9f28974e1d56/html5/thumbnails/14.jpg)
![Page 15: Indicazioni alla terapia adiuvante...IALT Advances m Management of Early Stage Non Small Cell Lung Cancer -Accrual 1867 / 3300 - Median Survival 50.8 months vs 44.4 months .Patient](https://reader030.vdocuments.site/reader030/viewer/2022011915/5fcdef678e5f9f28974e1d56/html5/thumbnails/15.jpg)
![Page 16: Indicazioni alla terapia adiuvante...IALT Advances m Management of Early Stage Non Small Cell Lung Cancer -Accrual 1867 / 3300 - Median Survival 50.8 months vs 44.4 months .Patient](https://reader030.vdocuments.site/reader030/viewer/2022011915/5fcdef678e5f9f28974e1d56/html5/thumbnails/16.jpg)
![Page 17: Indicazioni alla terapia adiuvante...IALT Advances m Management of Early Stage Non Small Cell Lung Cancer -Accrual 1867 / 3300 - Median Survival 50.8 months vs 44.4 months .Patient](https://reader030.vdocuments.site/reader030/viewer/2022011915/5fcdef678e5f9f28974e1d56/html5/thumbnails/17.jpg)
![Page 18: Indicazioni alla terapia adiuvante...IALT Advances m Management of Early Stage Non Small Cell Lung Cancer -Accrual 1867 / 3300 - Median Survival 50.8 months vs 44.4 months .Patient](https://reader030.vdocuments.site/reader030/viewer/2022011915/5fcdef678e5f9f28974e1d56/html5/thumbnails/18.jpg)
![Page 19: Indicazioni alla terapia adiuvante...IALT Advances m Management of Early Stage Non Small Cell Lung Cancer -Accrual 1867 / 3300 - Median Survival 50.8 months vs 44.4 months .Patient](https://reader030.vdocuments.site/reader030/viewer/2022011915/5fcdef678e5f9f28974e1d56/html5/thumbnails/19.jpg)
![Page 20: Indicazioni alla terapia adiuvante...IALT Advances m Management of Early Stage Non Small Cell Lung Cancer -Accrual 1867 / 3300 - Median Survival 50.8 months vs 44.4 months .Patient](https://reader030.vdocuments.site/reader030/viewer/2022011915/5fcdef678e5f9f28974e1d56/html5/thumbnails/20.jpg)
![Page 21: Indicazioni alla terapia adiuvante...IALT Advances m Management of Early Stage Non Small Cell Lung Cancer -Accrual 1867 / 3300 - Median Survival 50.8 months vs 44.4 months .Patient](https://reader030.vdocuments.site/reader030/viewer/2022011915/5fcdef678e5f9f28974e1d56/html5/thumbnails/21.jpg)
![Page 22: Indicazioni alla terapia adiuvante...IALT Advances m Management of Early Stage Non Small Cell Lung Cancer -Accrual 1867 / 3300 - Median Survival 50.8 months vs 44.4 months .Patient](https://reader030.vdocuments.site/reader030/viewer/2022011915/5fcdef678e5f9f28974e1d56/html5/thumbnails/22.jpg)
![Page 23: Indicazioni alla terapia adiuvante...IALT Advances m Management of Early Stage Non Small Cell Lung Cancer -Accrual 1867 / 3300 - Median Survival 50.8 months vs 44.4 months .Patient](https://reader030.vdocuments.site/reader030/viewer/2022011915/5fcdef678e5f9f28974e1d56/html5/thumbnails/23.jpg)
![Page 24: Indicazioni alla terapia adiuvante...IALT Advances m Management of Early Stage Non Small Cell Lung Cancer -Accrual 1867 / 3300 - Median Survival 50.8 months vs 44.4 months .Patient](https://reader030.vdocuments.site/reader030/viewer/2022011915/5fcdef678e5f9f28974e1d56/html5/thumbnails/24.jpg)
![Page 25: Indicazioni alla terapia adiuvante...IALT Advances m Management of Early Stage Non Small Cell Lung Cancer -Accrual 1867 / 3300 - Median Survival 50.8 months vs 44.4 months .Patient](https://reader030.vdocuments.site/reader030/viewer/2022011915/5fcdef678e5f9f28974e1d56/html5/thumbnails/25.jpg)
![Page 26: Indicazioni alla terapia adiuvante...IALT Advances m Management of Early Stage Non Small Cell Lung Cancer -Accrual 1867 / 3300 - Median Survival 50.8 months vs 44.4 months .Patient](https://reader030.vdocuments.site/reader030/viewer/2022011915/5fcdef678e5f9f28974e1d56/html5/thumbnails/26.jpg)
![Page 27: Indicazioni alla terapia adiuvante...IALT Advances m Management of Early Stage Non Small Cell Lung Cancer -Accrual 1867 / 3300 - Median Survival 50.8 months vs 44.4 months .Patient](https://reader030.vdocuments.site/reader030/viewer/2022011915/5fcdef678e5f9f28974e1d56/html5/thumbnails/27.jpg)
![Page 28: Indicazioni alla terapia adiuvante...IALT Advances m Management of Early Stage Non Small Cell Lung Cancer -Accrual 1867 / 3300 - Median Survival 50.8 months vs 44.4 months .Patient](https://reader030.vdocuments.site/reader030/viewer/2022011915/5fcdef678e5f9f28974e1d56/html5/thumbnails/28.jpg)
![Page 29: Indicazioni alla terapia adiuvante...IALT Advances m Management of Early Stage Non Small Cell Lung Cancer -Accrual 1867 / 3300 - Median Survival 50.8 months vs 44.4 months .Patient](https://reader030.vdocuments.site/reader030/viewer/2022011915/5fcdef678e5f9f28974e1d56/html5/thumbnails/29.jpg)
![Page 30: Indicazioni alla terapia adiuvante...IALT Advances m Management of Early Stage Non Small Cell Lung Cancer -Accrual 1867 / 3300 - Median Survival 50.8 months vs 44.4 months .Patient](https://reader030.vdocuments.site/reader030/viewer/2022011915/5fcdef678e5f9f28974e1d56/html5/thumbnails/30.jpg)
![Page 31: Indicazioni alla terapia adiuvante...IALT Advances m Management of Early Stage Non Small Cell Lung Cancer -Accrual 1867 / 3300 - Median Survival 50.8 months vs 44.4 months .Patient](https://reader030.vdocuments.site/reader030/viewer/2022011915/5fcdef678e5f9f28974e1d56/html5/thumbnails/31.jpg)
![Page 32: Indicazioni alla terapia adiuvante...IALT Advances m Management of Early Stage Non Small Cell Lung Cancer -Accrual 1867 / 3300 - Median Survival 50.8 months vs 44.4 months .Patient](https://reader030.vdocuments.site/reader030/viewer/2022011915/5fcdef678e5f9f28974e1d56/html5/thumbnails/32.jpg)
![Page 33: Indicazioni alla terapia adiuvante...IALT Advances m Management of Early Stage Non Small Cell Lung Cancer -Accrual 1867 / 3300 - Median Survival 50.8 months vs 44.4 months .Patient](https://reader030.vdocuments.site/reader030/viewer/2022011915/5fcdef678e5f9f28974e1d56/html5/thumbnails/33.jpg)
![Page 34: Indicazioni alla terapia adiuvante...IALT Advances m Management of Early Stage Non Small Cell Lung Cancer -Accrual 1867 / 3300 - Median Survival 50.8 months vs 44.4 months .Patient](https://reader030.vdocuments.site/reader030/viewer/2022011915/5fcdef678e5f9f28974e1d56/html5/thumbnails/34.jpg)
![Page 35: Indicazioni alla terapia adiuvante...IALT Advances m Management of Early Stage Non Small Cell Lung Cancer -Accrual 1867 / 3300 - Median Survival 50.8 months vs 44.4 months .Patient](https://reader030.vdocuments.site/reader030/viewer/2022011915/5fcdef678e5f9f28974e1d56/html5/thumbnails/35.jpg)
![Page 36: Indicazioni alla terapia adiuvante...IALT Advances m Management of Early Stage Non Small Cell Lung Cancer -Accrual 1867 / 3300 - Median Survival 50.8 months vs 44.4 months .Patient](https://reader030.vdocuments.site/reader030/viewer/2022011915/5fcdef678e5f9f28974e1d56/html5/thumbnails/36.jpg)
![Page 37: Indicazioni alla terapia adiuvante...IALT Advances m Management of Early Stage Non Small Cell Lung Cancer -Accrual 1867 / 3300 - Median Survival 50.8 months vs 44.4 months .Patient](https://reader030.vdocuments.site/reader030/viewer/2022011915/5fcdef678e5f9f28974e1d56/html5/thumbnails/37.jpg)
![Page 38: Indicazioni alla terapia adiuvante...IALT Advances m Management of Early Stage Non Small Cell Lung Cancer -Accrual 1867 / 3300 - Median Survival 50.8 months vs 44.4 months .Patient](https://reader030.vdocuments.site/reader030/viewer/2022011915/5fcdef678e5f9f28974e1d56/html5/thumbnails/38.jpg)
![Page 39: Indicazioni alla terapia adiuvante...IALT Advances m Management of Early Stage Non Small Cell Lung Cancer -Accrual 1867 / 3300 - Median Survival 50.8 months vs 44.4 months .Patient](https://reader030.vdocuments.site/reader030/viewer/2022011915/5fcdef678e5f9f28974e1d56/html5/thumbnails/39.jpg)
![Page 40: Indicazioni alla terapia adiuvante...IALT Advances m Management of Early Stage Non Small Cell Lung Cancer -Accrual 1867 / 3300 - Median Survival 50.8 months vs 44.4 months .Patient](https://reader030.vdocuments.site/reader030/viewer/2022011915/5fcdef678e5f9f28974e1d56/html5/thumbnails/40.jpg)
![Page 41: Indicazioni alla terapia adiuvante...IALT Advances m Management of Early Stage Non Small Cell Lung Cancer -Accrual 1867 / 3300 - Median Survival 50.8 months vs 44.4 months .Patient](https://reader030.vdocuments.site/reader030/viewer/2022011915/5fcdef678e5f9f28974e1d56/html5/thumbnails/41.jpg)
TRANSCRIPT
Indicazioni alla terapiaadiuvante
Vito LorussoDipartimento di Oncologia Medica
Istituto Oncologico Bari